A comprehensive review of 19 studies involving nearly 16 million individuals suggests that ADHD is linked to a 71% increase in the risk of early death. However, the data also indicates that prescribed medications may reduce this risk by 25%.
The 71 Percent Surge in Early Mortality Risk
According to a new review published in JAMA Network Open, individuals diagnosed with attention-deficit/hyperactivity disorder (ADHD) face a significantly higher risk of premature death compared to the general population. The research, led by scientists at the University of Liverpool in collaboration with University College London,analyzed data across three continents, with some participants traccked for over two decades.
The findings suggest that the risks associated with ADHD are not limited to a single cause but are wide-ranging. Joshua Stott, a professor of aging and clinical psychology at University College London, noted that the evidence points toward broad health inequalities that affect those living with the condition throughout their lives.
An 89 Percent Spike in Suicide and Injury Deaths
The data reveals a harrowing breakdown of how these early deaths occur. The risk of death by suicide nearly doubled for people with ADHD, representing an 89% increase. Furthermore, the review found that deaths resulting from intentional or unintentional injuries—including motor vehicle accidents—were 55% higher than in the non-ADHD population.
Beyond these unnatural causes, the study found that deaths from natural causes, such as diabetes and cardiovascular disease, were 27% higher. This suggests that the physiological and behavioral impacts of ADHD extend far beyond the cognitive symptoms of restlessness and impulsiveness.
The 25 Percent Benefit Found in Three Preliminary Studies
While the overall risks are high, the JAMA Network Open report highlights a potential silver lining: prescribed ADHD medication was linked to a 25% lower risk of death from any cause. However, lead author Lucy Corrigan, a psychologist at the University of Liverpool, cautioned that these results are preliminary, as they were derived from only three of the 19 studies analyzed.
The effectiveness of these drugs, which include both stimulants and non-stimulants, remains a point of contention in the medical community.. While some data suggests a decline in suicidal behavior, other studies have been inconclusive, meaning further research is required to establish a definitive cause-and-effect relationship between medication and longevity.
The 8.64-Year Life Expectancy Gap for Women
This research echoes previous findings regarding the long-term toll of the disorder. As reported in the source,a separate study conducted last year found that diagnosed ADHD was linked to a reduction in life expectancy of 6.78 years for men and 8.64 years for women.. These disparities are often compounded by "executive function challenges," which make it difficult for patients to manage chronic health conditions or maintain consistent medical appointments.
Dr. Elizabeth Landsverk, an expert in geriatric medicine, suggests that the organizational struggles inherent in ADHD may also contribute to a higher risk of cognitive impairment in later life. Additionally, the struggle to maintain steady employment often leads to prolonged stress, further eroding long-term health outcomes.
Why Socioeconomic Factors Remained Uncontrolled
Despite the scale of the data, the researchers admit significant gaps in the evidence. because the 19 studies were observational, they cannot prove that ADHD causes early death. A critical missing piece is the lack of control for socioeconomic status and co-occurring mental health conditions across the various data sets.
There are also geographical discrepancies in how the condition is handled. diagnosis rates are notably higher in the United States than in other countries, leading some researchers to question whether cultural factors are driving overdiagnosis or if the U.S. simply has higher awareness. Without standardized diagnostic criteria and tracking methods, the exact weight of environmental factors—such as early exposure to lead or other toxins—remains an open question.
Comments 0